Document is current
Any future updates will be listed below
-
Authors
Huang, Lin https://orcid.org/0000-0002-6768-1141
Petersen, René Horsleben https://orcid.org/0000-0002-3586-1869
Kehlet, Henrik https://orcid.org/0000-0002-2209-1711
-
Funding
Funding for this research was provided by:
Rigshospitalet (R163-A7357-B5343)
Novo Nordisk Fonden (NNF22OC0079013)
Copenhagen University
- License Information
-
More Information
Article History
Received: 4 March 2024
Accepted: 17 May 2024
First Online: 7 June 2024
Declarations
:
: RHP reports speaker fee from Medtronic, Medela, AstraZeneca and AMBU, advisory board member for AstraZeneca, MSD, BMS and Roche. The other authors have no conflict of interest to report.
